Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study
about
Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challengesBone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San FranciscoTotal body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients.Renal transplantation in patients with HIV.Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir usersLow bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study.Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications.Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required.Bone Density and Fractures in HIV-infected Postmenopausal Women: A Systematic Review.Care of the human immunodeficiency virus-infected menopausal woman.Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapyAntiviral agents and HIV prevention: controversies, conflicts, and consensus.Vitamin D in HIV-Infected Patients.What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review.Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiationBone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy.The Promise of Antiretrovirals for HIV Prevention.Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142.Bone mineral density in HIV-infected women taking antiretroviral therapy: a systematic review.The effects of exercise training on metabolic and morphological outcomes for people living with HIV: a systematic review of randomised controlled trials.Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection.Sex Differences in Tobacco Use Among Persons Living With HIV/AIDS: A Systematic Review and Meta-Analysis.Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s.TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared to Men.British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q27023352-D8AFFFC2-C1C4-4531-AD1B-E1986FFE3C73Q28476730-B4EDF2A4-A914-40FF-9BD4-80662E119C89Q33532361-CA443B52-D0C6-4AD3-953F-1AC4E6766C93Q33643157-2D2ECCC8-5BBF-4AC4-9D49-119C90913BE1Q34079397-B3B55C8E-BF9F-467F-BAED-D3E8B95B4723Q34116648-B0F08820-6230-4024-A87A-E92921EA6758Q34213832-321F87B6-776E-4328-811B-C349232FD7BBQ34264297-C25D9968-7399-4A5F-9FEA-2B8DDD373E19Q35291766-AF880810-2F22-40D1-A076-602639C25BFCQ35505203-16F4BC1A-6236-4D68-B4D4-AD4B7856C6F7Q35619304-082F41FD-8C07-4385-AE67-A04E77FB7271Q36033710-2D9560ED-1E2B-450B-95AC-4618AC61CEDBQ36069498-2E935414-8DAF-41B2-B8D5-B1C3F5969129Q36128333-8727910C-DFDC-4553-836D-D13F9907C46EQ36456570-9D32986E-7CD3-440D-A229-A6B3A3CE37EDQ36836680-BFBD35C3-C996-4215-9908-02FE934A733DQ36884537-A23FFE6E-E96D-4527-B5FA-15A5A026973DQ37215398-B4D6C631-B06E-4058-9AA2-C2181BC951BFQ37247235-F68689C7-E9D0-4055-97E1-180B43047B54Q37272765-8C4E347D-2AE6-48ED-9DA6-34497043EC2DQ37511883-DA355651-82FC-46A0-BF80-F8FE24F79C5DQ37641866-298E0E8F-BBF8-4090-9A4A-1F4928DEB86FQ37756578-6A8ADAE9-211F-4D9D-A344-DBD3EA55C705Q37815335-4E92AEAC-DB22-4EFE-8380-A0789EBE192CQ38435884-053DC301-D695-495C-83BB-FB0B60F7768AQ39046688-FB7807CF-BE2E-4BC3-B920-81612C6CDF8FQ40267569-293747D2-C21F-4E10-8647-78D395DF18F0Q43923848-C5463553-028E-4468-8FFB-7DC0C26825EEQ46400137-FDF14886-751A-40B0-AE72-40ADAE1D0BB7Q57180790-3095A83D-855A-4740-9D88-697EDD786025
P2860
Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Evolution and predictors of ch ...... ition for healthy living study
@en
Evolution and predictors of ch ...... tion for healthy living study.
@nl
type
label
Evolution and predictors of ch ...... ition for healthy living study
@en
Evolution and predictors of ch ...... tion for healthy living study.
@nl
prefLabel
Evolution and predictors of ch ...... ition for healthy living study
@en
Evolution and predictors of ch ...... tion for healthy living study.
@nl
P2860
P1476
Evolution and predictors of ch ...... ition for healthy living study
@en
P2093
Denise L Jacobson
Tamsin K Knox
P2860
P304
P356
10.1097/QAI.0B013E3181893E8E
P407
P577
2008-11-01T00:00:00Z